1. Home
  2. ASMB vs TMQ Comparison

ASMB vs TMQ Comparison

Compare ASMB & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • TMQ
  • Stock Information
  • Founded
  • ASMB 2005
  • TMQ 2004
  • Country
  • ASMB United States
  • TMQ Canada
  • Employees
  • ASMB N/A
  • TMQ N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • ASMB Health Care
  • TMQ Basic Materials
  • Exchange
  • ASMB Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • ASMB 84.5M
  • TMQ 83.6M
  • IPO Year
  • ASMB 2010
  • TMQ N/A
  • Fundamental
  • Price
  • ASMB $13.30
  • TMQ $1.29
  • Analyst Decision
  • ASMB Buy
  • TMQ
  • Analyst Count
  • ASMB 2
  • TMQ 0
  • Target Price
  • ASMB $35.00
  • TMQ N/A
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • TMQ 339.8K
  • Earning Date
  • ASMB 03-27-2025
  • TMQ 04-02-2025
  • Dividend Yield
  • ASMB N/A
  • TMQ N/A
  • EPS Growth
  • ASMB N/A
  • TMQ N/A
  • EPS
  • ASMB N/A
  • TMQ N/A
  • Revenue
  • ASMB $28,326,000.00
  • TMQ N/A
  • Revenue This Year
  • ASMB $282.16
  • TMQ N/A
  • Revenue Next Year
  • ASMB N/A
  • TMQ N/A
  • P/E Ratio
  • ASMB N/A
  • TMQ N/A
  • Revenue Growth
  • ASMB N/A
  • TMQ N/A
  • 52 Week Low
  • ASMB $11.01
  • TMQ $0.25
  • 52 Week High
  • ASMB $19.93
  • TMQ $1.48
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • TMQ 56.43
  • Support Level
  • ASMB $13.13
  • TMQ $1.22
  • Resistance Level
  • ASMB $14.25
  • TMQ $1.38
  • Average True Range (ATR)
  • ASMB 0.55
  • TMQ 0.10
  • MACD
  • ASMB -0.07
  • TMQ -0.00
  • Stochastic Oscillator
  • ASMB 15.38
  • TMQ 54.05

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: